Literature DB >> 27353564

Mechanistic study of the inhibitory activity of Geum urbanum extract against α-Synuclein fibrillation.

Eva S Lobbens1, Leonid Breydo2, Thomas Skamris3, Bente Vestergaard3, Anna K Jäger3, Lene Jorgensen1, Vladimir Uversky4, Marco van de Weert5.   

Abstract

The presence of Lewy bodies and Lewy neurites is a major pathological hallmark of Parkinson's disease and is hypothesized to be linked to disease development, although this is not yet conclusive. Lewy bodies and Lewy neurites primarily consist of fibrillated α-Synuclein; yet, there is no treatment available targeting stabilization of α-Synuclein in its native state. The aim of the present study was to investigate the inhibitory activity of an ethanolic extract of Geum urbanum against α-Synuclein fibrillation and examine the structural changes of α-Synuclein in the presence of the extract. The anti-fibrillation and anti-aggregation activities of the plant extract were monitored by thioflavin T fibrillation assays and size exclusion chromatography, while structural changes were followed by circular dichroism, Fourier transform infrared spectroscopy, intrinsic fluorescence, small angle X-ray scattering and electron microscopy. Since the extract is a complex mixture, structure-function relationships could not be determined. Under the experimental conditions investigated, Geum urbanum was found to inhibit α-Synuclein fibrillation in a concentration dependent way, and to partly disintegrate preformed α-Synuclein fibrils. Based on the structural changes of α-Synuclein in the presence of extract, we propose that Geum urbanum delays α-Synuclein fibrillation either by reducing the fibrillation ability of one or more of the aggregation prone intermediates or by directing α-Synuclein aggregation towards a non-fibrillar state. However, whether these alterations of the fibrillation pathway lead to less pathogenic species is yet to be determined.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Amyloid fibrillation; Inhibition of fibrillation; Natural products; Traditional medicine; α-Synuclein

Mesh:

Substances:

Year:  2016        PMID: 27353564     DOI: 10.1016/j.bbapap.2016.06.009

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  6 in total

Review 1.  Looking at the recent advances in understanding α-synuclein and its aggregation through the proteoform prism.

Authors:  Vladimir N Uversky
Journal:  F1000Res       Date:  2017-04-20

2.  Early Stage Alpha-Synuclein Amyloid Fibrils are Reservoirs of Membrane-Binding Species.

Authors:  Thomas Skamris; Carlotta Marasini; Kenneth L Madsen; Vito Foderà; Bente Vestergaard
Journal:  Sci Rep       Date:  2019-02-11       Impact factor: 4.379

3.  The Hydroalcoholic Extract of Saffron Protects PC12 Cells against Aluminum-Induced Cell Death and Oxidative Stress in Vitro.

Authors:  Shokofeh Rahmani; Jamileh Saberzadeh; Mohammad Ali Takhshid
Journal:  Iran J Med Sci       Date:  2020-01

4.  Andrographolide inhibits human serum albumin fibril formations through site-specific molecular interactions.

Authors:  Aalok Basu; Sagar Bhayye; Sonia Kundu; Aatryee Das; Arup Mukherjee
Journal:  RSC Adv       Date:  2018-08-31       Impact factor: 4.036

5.  Brazilin Removes Toxic Alpha-Synuclein and Seeding Competent Assemblies from Parkinson Brain by Altering Conformational Equilibrium.

Authors:  George R Nahass; Yuanzi Sun; Yong Xu; Mark Batchelor; Madeleine Reilly; Iryna Benilova; Niraja Kedia; Kevin Spehar; Frank Sobott; Richard B Sessions; Byron Caughey; Sheena E Radford; Parmjit S Jat; John Collinge; Jan Bieschke
Journal:  J Mol Biol       Date:  2021-02-19       Impact factor: 5.469

6.  Protective effect of Vigna unguiculata extract against aging and neurodegeneration.

Authors:  Farida Tripodi; Linda Lombardi; Lorenzo Guzzetti; Davide Panzeri; Riccardo Milanesi; Manuela Leri; Monica Bucciantini; Cristina Angeloni; Daniela Beghelli; Silvana Hrelia; Giada Onorato; Elia Di Schiavi; Ermelinda Falletta; Simona Nonnis; Gabriella Tedeschi; Massimo Labra; Paola Coccetti
Journal:  Aging (Albany NY)       Date:  2020-10-05       Impact factor: 5.682

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.